News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

Gaize
|
September 5, 2024

Device developed by Missoula company Gaize (gaize.ai) could help to keep people safe at work and on the road.

C2M Beta
|
August 19, 2024

2M Beta is a 12-week program delivering the foundational and modern skills required to transform influential ideas into thriving businesses. With access to more professional expertise, more state-of-the-art technology and more community resources, C2M Beta was founded with the mission to connect local entrepreneurs to more!

Montana BioScience Alliance
|
July 25, 2024

A message from Board President Cynthia Tsai

SPI Pharma, Inc. a global leader in biopharmaceutical excipient and adjuvant systems, and Inimmune, Corp., a pioneering biotechnology company specializing in the discovery and development of innate immune modulators, announce an agreement in principle to create a strategic collaboration to develop and commercialize advanced adjuvant systems for vaccine development. This collaboration leverages Inimmune’s world-class expertise in adjuvant formulation and immunotherapeutics and SPI Pharma’s extensive manufacturing and global commercial capabilities.

National Institutes of Health — Rocky Mountain Laboratories
|
May 21, 2024

NIAID scientists and colleagues are investigating a potential treatment strategy against Lyme disease that would directly suppress Borrelia burgdorferi, the bacterium that causes the disease. If successful, their idea could reduce or end aggressive broad-spectrum antibiotic treatments that can be drawn-out and destroy the body’s helpful bacteria.

ARTICLES OF INTEREST

The House Appropriations Committee has approved its FY 2023 spending bill including a $2.5 billion funding increase for the National Institutes of Health (NIH), a $466 million funding boost for the National Cancer Institute (NCI) and $2.75 billion for the Advanced Research Projects Agency on Health (ARPA-H). The bill increases current funding levels for the Centers for Disease Control and Prevention (CDC) cancer screening and early detection programs and for the CDC’s Office on Smoking and Health, which provides funding for programs […]

American Cancer Society Cancer Action Network
|
July 2, 2022

Biomarker testing helps connect patients with the most effective treatments for their cancer – but not all patients are benefiting from the latest advances in cancer treatment. Learn how biomarker testing helps cancer patients and what can be done to improve access and advance health equity.

Bio event draws about 3,000 companies to the San Diego Convention Center to take stock of the latest trends and research.

Four-time gold medalist and seven-time Grand Slam singles champion Venus Williams will discuss her groundbreaking career, business success, and prioritizing health in a conversation moderated by Emmy-nominated sports reporter Erin Andrews at the BIO International Convention June 13-16, 2022, in San Diego. Both women have faced their own health challenges, becoming advocates for increased awareness and better outcomes for all.

New York Times
|
May 21, 2022

As the pandemic enters its third year, long Covid has emerged as an increasingly important concern. And many people are wondering whether getting a Covid shot can reduce their chances of developing long-term symptoms.

NEWSLETTER

Newsletter
|
August 26, 2024

View the September 2024 Newsletter now!

Newsletter
|
July 25, 2024

View the Summer 2024 Newsletter now!